GoodRx Holdings Inc (GDRX)

[@LaughinPaulRyan]

... $JPM Sees Doom And Gloom in $GDRX ...

@LootWallStreet vehemently juxtaposes this inconceivable err.

Although Anmuth expects Amazon’s offerings to have limited near-term impact, once customers become aware of the benefits of Prime Rx’ discount card and 2-day home delivery, Anmuth expects Amazon Pharmacy will be a “direct risk over the next few years.”

As a result, Anmuth downgraded GoodRx's rating from Neutral (i.e. Hold) to Underweight (i.e. Sell). The price target gets a severe haircut, too, and is reduced from $59 to $29. The new figure implies a 23% downside from current levels.

#Takeover